JP2022552200A5 - - Google Patents

Info

Publication number
JP2022552200A5
JP2022552200A5 JP2022520980A JP2022520980A JP2022552200A5 JP 2022552200 A5 JP2022552200 A5 JP 2022552200A5 JP 2022520980 A JP2022520980 A JP 2022520980A JP 2022520980 A JP2022520980 A JP 2022520980A JP 2022552200 A5 JP2022552200 A5 JP 2022552200A5
Authority
JP
Japan
Prior art keywords
item
antigen
agonist
glycero
palmitoyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2022520980A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022552200A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2020/054621 external-priority patent/WO2021071977A1/en
Publication of JP2022552200A publication Critical patent/JP2022552200A/ja
Publication of JP2022552200A5 publication Critical patent/JP2022552200A5/ja
Pending legal-status Critical Current

Links

JP2022520980A 2019-10-07 2020-10-07 樹状細胞およびT細胞の活性化を増強するためのならびにTH-1免疫応答を誘導するためのin vitroの方法および組成物 Pending JP2022552200A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201962912005P 2019-10-07 2019-10-07
US62/912,005 2019-10-07
PCT/US2020/054621 WO2021071977A1 (en) 2019-10-07 2020-10-07 In vitro methods and compositions for enhancing the activation of dendritic cells and t cells, and for inducing a th-1 immune response

Publications (2)

Publication Number Publication Date
JP2022552200A JP2022552200A (ja) 2022-12-15
JP2022552200A5 true JP2022552200A5 (https=) 2023-10-18

Family

ID=75437644

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2022520980A Pending JP2022552200A (ja) 2019-10-07 2020-10-07 樹状細胞およびT細胞の活性化を増強するためのならびにTH-1免疫応答を誘導するためのin vitroの方法および組成物

Country Status (11)

Country Link
US (1) US20240122975A1 (https=)
EP (1) EP4041298A4 (https=)
JP (1) JP2022552200A (https=)
KR (1) KR20220098351A (https=)
CN (1) CN115461073A (https=)
AU (1) AU2020363707A1 (https=)
BR (1) BR112022006743A2 (https=)
CA (1) CA3157004A1 (https=)
IL (1) IL292009A (https=)
MX (1) MX2022004186A (https=)
WO (1) WO2021071977A1 (https=)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2018501322A (ja) 2015-01-12 2018-01-18 チルドレンズ メディカル センター コーポレーション トール様受容体4アンタゴニストの炎症促進性およびアジュバント機能
EP4061423A4 (en) * 2019-11-18 2023-12-06 Children's Medical Center Corporation HYPERACTIVE DENDRITIC CELLS FOR PERMANENT ANTITUMOR EFFECT ON ADOPTIONAL CELL TRANSFER BASIS
WO2024151124A1 (ko) * 2023-01-12 2024-07-18 주식회사 이뮤노맥스 항암능이 우수한 기억 t 세포 유래 면역세포치료제의 제조방법

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2459713C (en) * 2001-09-06 2015-08-18 Northwest Biotherapeutics, Inc. Compositions and methods for priming monocytic dendritic cells and t cells for th-1 response
JP2018501322A (ja) * 2015-01-12 2018-01-18 チルドレンズ メディカル センター コーポレーション トール様受容体4アンタゴニストの炎症促進性およびアジュバント機能
IL256522B2 (en) * 2015-06-30 2024-10-01 Northwest Biotherapeutics Inc Optimally activated dendritic cells that result in an enhanced or enhanced antitumor immune response
RU2749610C2 (ru) * 2015-09-15 2021-06-16 Нортвест Байотерапьютикс, Инк. Способы, относящиеся к композициям активированных дендритных клеток и к иммунотерапевтическому лечению индивидуумов с прогрессирующим раком

Similar Documents

Publication Publication Date Title
Liau et al. Treatment of intracranial gliomas with bone marrow—derived dendritic cells pulsed with tumor antigens
ES2766299T3 (es) Composiciones y procedimientos para la activación linfocitaria de células dendríticas monocíticas y células T para generar una respuesta Th-1
Ashley et al. Bone marrow–generated dendritic cells pulsed with tumor extracts or tumor RNA induce antitumor immunity against central nervous system tumors
CN102165057B (zh) 用于主动或过继性细胞疗法的类浆细胞树突细胞系
CN100337686C (zh) 从前体产生加载有抗原的树突细胞疫苗的快速一步法
JP2022552200A5 (https=)
US20090297541A1 (en) Maturation of dendritic cells
IL169002A (en) A preparation containing partially dendritic cells in vitro
WO2005060966A1 (fr) Composition immunostimulante comprenant au moins un agoniste des recepteurs toll-like 7 ou du recepteur toll-like 8 et un agoniste du recepteur toll-like 4
CN115461073A (zh) 用于增强树突细胞和T细胞激活以及用于诱导Th-1免疫应答的体外方法和组合物
JP2018523996A5 (https=)
RU2018103235A (ru) Оптимально активированные дендритные клетки, индуцирующие улучшенный или повышенный противоопухолевый иммунный ответ
WO2004053095A2 (en) In situ maturation of dendritic cells
IL258071A (en) Methods related to activated branch cell preparations and immunotherapeutic therapies for patients with advanced cancer
KR101117186B1 (ko) 수지상세포의 이동성 증진 및 수지상세포에 의해 제조된 세포독성 t 세포의 세포살상능 증진방법
AU2003246396B2 (en) A method for generating antigen-presenting cells
JP2018537949A5 (https=)
EP1484064A1 (en) Therapeutical composition containing dentritic cells and use thereof
CA2454734A1 (en) New isolated dendritic cells, a process for preparing the same and their use in pharmaceutical compositions
HK40085184A (en) In vitro methods and compositions for enhancing the activation of dendritic cells and t cells, and for inducing a th-1 immune response
Shahum et al. Effect of liposomal antigens on the priming and activation of the immune system by dendritic cells
KR101083404B1 (ko) 수지상세포의 이동성 증진 및 수지상세포에 의해 제조된 세포독성 т 세포의 세포살상능 증진방법
WO2016135286A1 (en) Method for stimulating dendritic cells (dcs)
Nazarkina et al. Preparation of dendritic cells for cancer immunotherapy
CN106544319A (zh) 一种用于刺激树突状细胞成熟的组合物及其用于刺激树突状细胞成熟的方法